| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 10/03/2006 | US7115591 Pyridazinone compounds as cyclooxygenase [COX] 2 inhibitorsfor gastrointestinal disorders |
| 10/03/2006 | CA2352405C New diphenylurea derivatives, their preparation process and the pharmaceutical compounds that contain them |
| 10/03/2006 | CA2288241C Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination |
| 10/03/2006 | CA2277018C Use of angiotensin ii antagonists to treat symptomatic heart failure |
| 10/03/2006 | CA2187130C Novel sulphonamides |
| 09/28/2006 | WO2006101245A1 N-substituted-n-(4-piperidinyl) amide derivative |
| 09/28/2006 | WO2006101082A1 Pyrimidine compound crystal or amorphous form and process for producing the same |
| 09/28/2006 | WO2006101081A1 Crystal of 5-[2-amino-4-(2-furyl)pyrimidin-5-yl]-1- methylpyridin-2(1h)-one and process for producing the same |
| 09/28/2006 | WO2006100922A1 Cinnamoyl compound and use thereof |
| 09/28/2006 | WO2006100481A2 Preparations of 11c methyl iodide and of the radioligand 11c gb67 |
| 09/28/2006 | WO2006100208A1 1-benzylindole-2-carboxamide derivatives |
| 09/28/2006 | WO2006100106A1 3-carboxy pyrroles as anti-viral agents |
| 09/28/2006 | WO2006100036A1 3, 4-substituted pyrrolidine derivatives for the treatment of hypertension |
| 09/28/2006 | WO2006100009A1 Cgrp antagonists, method for the production thereof, and their use as medicaments |
| 09/28/2006 | WO2006099974A1 N-aryl-sulfoximine-substituted pyrimidines as cdk- and/or vegf inhibitors, their production and use as pharmaceutical agents |
| 09/28/2006 | WO2006072608A3 Aryl piperazine derivatives for the treatment of neuropsychiatric disorders |
| 09/28/2006 | WO2006055725A3 Substituted amino acids as protein tyrosine phosphatase inhibitors |
| 09/28/2006 | WO2006053342A3 Integrin antagonists useful as anticancer agents |
| 09/28/2006 | WO2006047503A3 Inhibitors of c-fms kinase |
| 09/28/2006 | WO2006025979A3 Modulators of nuclear receptors |
| 09/28/2006 | WO2005013914A8 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 09/28/2006 | US20060217553 chemical preparation of diketopiperizine derivatives; useful as anticarcinogenic and antifungal agent |
| 09/28/2006 | US20060217432 3,6-Disubstituted azabicyclo [3.1.0] hexane derivatives as muscarinic receptor antagonists |
| 09/28/2006 | US20060217427 Cytoskeletal active compounds, compositions and use |
| 09/28/2006 | US20060217426 Compound inhibiting in vivo phosphorous transport and medicine containing the same |
| 09/28/2006 | US20060217422 cyclization of a 1,4-dioxaspiro[4,5]decane, by heating in solvents and treating with a base, to give a spiro[1,3-dioxolane-2,6'-1,3a,5,7,8,8a,9,9a-octahydrobenzo[f][2]benzofuran]-3'-one-9'-carboxamide, useful in the treatment of thrombotic, inflammatory, atherosclerotic and fibroproliferative disorders |
| 09/28/2006 | US20060217418 Antagonists for melanin concentrating hormone-1 receptors; antidepressants, anxiolytic agents; incontinence, obesity |
| 09/28/2006 | US20060217399 Phenyl quinolines and their use as estrogenic agents |
| 09/28/2006 | US20060217379 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 09/28/2006 | US20060217372 Diaryl ethers as opioid receptor antagonist |
| 09/28/2006 | CA2601135A1 Synthesis of avrainvillamide, stephacidin b, and analogues thereof |
| 09/28/2006 | CA2600909A1 Cgrp antagonists, method for the production thereof, and their use as medicaments |
| 09/28/2006 | CA2600063A1 3, 4-substituted pyrrolidine derivatives for the treatment of hypertension |
| 09/28/2006 | CA2599855A1 1-benzylindole-2-carboxamide derivatives |
| 09/28/2006 | CA2599794A1 Cinnamoyl compound and use thereof |
| 09/28/2006 | CA2596737A1 Pyrimidine compound crystal or amorphous form and process for producing the same |
| 09/28/2006 | CA2596735A1 Crystal of 5-[2-amino-4-(2-furyl)pyrimidin-5-yl]-1- methylpyridin-2(1h)-one and processes for producing the same |
| 09/27/2006 | EP1705179A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 09/27/2006 | EP1704145A1 Selective kinase inhibitors |
| 09/27/2006 | EP1704142A1 Protease inhibitors |
| 09/27/2006 | EP1703906A1 Immuno inhibitory pyrazolone compounds |
| 09/27/2006 | EP1703905A1 Indole derivatives and use thereof as kinase inhibitors in particular ikk2 inhibitors |
| 09/27/2006 | EP1703797A2 TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-κB ACTIVITY AND USE THEREOF |
| 09/27/2006 | EP1594840B1 Piperidine-benzenesulfonamide derivatives |
| 09/27/2006 | EP1421078B1 Indole derivatives as beta-3 adrenergic agonists for the treatment of type 2 diabetes |
| 09/27/2006 | EP1383757B1 Antagonists of mcp-1 function and methods of use thereof |
| 09/27/2006 | EP1335906B1 Pyrimidine derivatives and their use as neuropeptide y receptor ligands |
| 09/27/2006 | EP1286967B1 Cyclohexane derivatives and their use as therapeutic agents |
| 09/27/2006 | CN1839135A Tricyclic delta-opioid modulators |
| 09/27/2006 | CN1839126A Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders |
| 09/27/2006 | CN1837203A Chiral 4,4'-dimethoxy-5,6,5',6'-bis methylene dioxy -2,2'-phthalic acid derivatives and process for preparing same |
| 09/27/2006 | CN1837200A Tanshinone I derivatives and pharmaceutical application thereof |
| 09/27/2006 | CN1837193A Process for preparing diindolylmethane derivatives |
| 09/26/2006 | US7112600 A therapeutic agent for treating hepatitis C, based on polymerase inhibitory activity |
| 09/26/2006 | US7112595 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 09/26/2006 | US7112594 A N-phenyl-benzo(b)thiophene-carboxamide derivatives, as enzyme inhibitor of tyrosine kinase; antiproliferation of lymphocyte, treating autoimmune disease, rheumatic disease, as immunosuppressant, antiinflammatory agents |
| 09/26/2006 | US7112587 e.g., N-Cycloheptyl-N'(1-ethyl-pyrrolidin-2-ylmethyl)-6-(3-fluoro-4-methoxy-phenoxy)-[1,3,5]triazine-2,4-diamine; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme |
| 09/26/2006 | US7112553 Particularly isothiazolylamino- or pyridinylamino- substituted; e.g., N-[2-ethoxymethyl-4-chloro-3-methylisothiazolin-5-ylidene]-[2-(2-methylpropyl)indazol-5-yl)acetamide and N-(4-chloro-3-methylisothiazol-5-yl)-N-(ethoxymethyl)-(2-propylbenzotriazol-5-yl)acetamide |
| 09/26/2006 | CA2330686C Process for making 1,3-disubstituted-4-oxocyclic ureas |
| 09/26/2006 | CA2278694C Sulfamide-metalloprotease inhibitors |
| 09/21/2006 | WO2006099231A1 Pyrimidine derivatives for treatment of hyperproliferative disorders |
| 09/21/2006 | WO2006099193A2 Chromen-4-one inhibitors of anti-apoptotic bcl-2 family members and the uses thereof |
| 09/21/2006 | WO2006099167A1 Biphenyl compounds useful as muscarinic receptor antagonists |
| 09/21/2006 | WO2006099091A1 Biphenyl compounds useful as muscarinic receptor antagonists |
| 09/21/2006 | WO2006099032A1 Biphenyl compounds useful as muscarinic receptor antagonists |
| 09/21/2006 | WO2006099031A1 Biphenyl compounds useful as muscarinic receptor antagonists |
| 09/21/2006 | WO2006098999A1 Biphenyl compounds useful as muscarinic receptor antagonists |
| 09/21/2006 | WO2006098997A1 Biphenyl compounds useful as muscarinic receptor antagonists |
| 09/21/2006 | WO2006098918A2 Substituted gamma lactams as therapeutic agents |
| 09/21/2006 | WO2006098620A1 Use of derivatives comprising a coumarin group for the preparation of an antiviral agent, derivatives comprising a coumarin group, a method for the preparation thereof, and pharmaceutical compositions containing them |
| 09/21/2006 | WO2006098308A1 Novel anthranilic acid derivative or salt thereof |
| 09/21/2006 | WO2006097848A1 Hiv-1 virion maturation inhibitors, compositions and treatments using the same |
| 09/21/2006 | WO2006097808A1 Benzimidazolone derivatives as cb2 receptor ligands |
| 09/21/2006 | WO2006097730A1 Analogues of the azinomycins as anti-tumour agents and as prodrugs |
| 09/21/2006 | WO2006097474A1 N-sulphonylpyrroles and their use as histone deacetylase inhibitors |
| 09/21/2006 | WO2006097460A1 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them |
| 09/21/2006 | WO2006097441A1 Potassium channel modulating agents and their medical use |
| 09/21/2006 | WO2006097030A1 Bisheterocycle tandem compounds useful as antiviral agents, the uses thereof and the compositions comprising such compounds |
| 09/21/2006 | WO2006055760A9 Triazole compounds that modulate hsp90 activity |
| 09/21/2006 | WO2006002421A3 Modulators of atp-binding cassette transporters |
| 09/21/2006 | US20060211865 Use of pyridine N-oxide analogs at doses which do not induce emesis |
| 09/21/2006 | US20060211761 Hmg-coa-reductase inhibitors |
| 09/21/2006 | US20060211737 Anticancer, inflammation, arthritis, angiogenesis, neurodegenerative diseases, fungal infections, malaria; Heat-shock protein 90 inhibitors; 4-(6,6-Dimethyl-4-oxo-3-methyl-4,5,6,7-tetrahydro-indazol-1-yl)-2-(3,4,5-trimethoxyanilino)-benzamide |
| 09/21/2006 | US20060211736 Glutarimide-containing polyketide analogs and methods thereof |
| 09/21/2006 | US20060211730 Beta-sulfonamide hydroxamic acid inhibitors of tace/matrix metalloproteinase |
| 09/21/2006 | US20060211722 Amino cyclobutylamide modulators of chemokine receptor activity |
| 09/21/2006 | US20060211717 Quinoline and quinazoline derivatives and drugs containing the same |
| 09/21/2006 | US20060211694 antiinflammatory agent for treating asthma and chronic pulmonary inflammatory disease |
| 09/21/2006 | US20060211689 Aminoquinoline derivatives and their use as adenosine A3 ligands |
| 09/21/2006 | US20060211577 Benzenesulphonamide derivatives as herbicides or desiccant/defoliant compounds |
| 09/21/2006 | US20060211107 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 09/21/2006 | CA2759162A1 Benzazole derivatives, compositions, and methods of use as .beta.-secretase inhibitors |
| 09/21/2006 | CA2602609A1 Novel anthranilic acid derivative or salt thereof |
| 09/21/2006 | CA2601628A1 Certain substituted amides, method of making, and method of use thereof |
| 09/21/2006 | CA2601527A1 Potassium channel modulating agents and their medical use |
| 09/21/2006 | CA2601257A1 Pyrimidine derivatives for treatment of hyperproliferative disorders |
| 09/21/2006 | CA2600528A1 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them |
| 09/21/2006 | CA2599538A1 N-sulphonylpyrroles and their use as histone deacetylase inhibitors |
| 09/21/2006 | CA2599425A1 Substituted gamma lactams as therapeutic agents |
| 09/20/2006 | EP1702920A1 Pyrazole compounds useful as protein kinase inhibitors |